Are there clinical studies on zeolite?

Yes, PMA-Zeolite has been investigated in more than 50 scientific publications, including randomized, double-blind, placebo-controlled studies (RCTs). These studies demonstrate effectiveness in strengthening the intestinal barrier, selective heavy metal binding, and safety during long-term use.

Do the study results apply to all zeolite products?

No. The studies relate exclusively to PMA-Zeolite from PANACEO with the patented PMA activation process. The results cannot be transferred to other zeolite products, as purity, activation, and particle size significantly influence effectiveness.

Science & Research

Clinical studies on
PMA-Zeolite

More than 50 scientific publications demonstrate the effectiveness and safety of PMA-Zeolite. Here you will find an overview of all studies — compact, easy to understand, and with source references.

50+

Scientific publications

10+

Clinical human studies

RCT

Double-blind & placebo-controlled

20+

Years of research

Please note: The studies listed here relate exclusively to PMA-Zeolite from PANACEO and cannot be transferred to other zeolite products. The effect may vary individually and does not replace medical advice. If taking medication, observe the recommended safety interval.

Product safety & toxicology

Safety Class IIb

Research question

Is PMA-Zeolite safe for long-term use?

Method

Physicochemical characterization, toxicological testing including cytotoxicity, sensitization, irritation, subchronic toxicity, and genotoxicity

Result

No cytotoxicity, no sensitization, safe subchronic use even at multiple times the recommended dose. No mutagenicity. A 2018 review confirms safe long-term use.

Source: Technical information “Research on PMA-Zeolite” — safety/toxicology summary

Strengthening the intestinal barrier (leaky gut)

RCT double-blind Peer-reviewed

Research question

Can PMA-Zeolite improve intestinal wall integrity and reduce inflammatory markers?

Method

Randomized, double-blind, placebo-controlled study (RCT). Measurement of zonulin as a leaky gut marker as well as inflammatory parameters.

Result

Significant reduction in zonulin levels (marker of increased intestinal permeability). Trend toward anti-inflammatory signals. The intestinal barrier was demonstrably strengthened.

Source: Peer-reviewed publication — randomized controlled study

Selective binding of harmful substances in the gut

Peer-reviewed

Research question

Does PMA-Zeolite selectively bind heavy metals without affecting nutrient balance?

Method

Controlled clinical study. Measurement of lead, cadmium, arsenic, and ammonium in stool as well as mineral levels in blood.

Result

PMA-Zeolite selectively binds lead, cadmium, arsenic, and ammonium in the gastrointestinal tract. Mineral levels (Ca, Mg, K) remain unchanged — ion exchange works selectively.

Source: Peer-reviewed publication — clinical study

No aluminum release

Safety Clinical study

Research question

Is aluminum released from the zeolite crystal lattice during use?

Method

Measurement of blood aluminum levels before, during, and after 3 months of daily intake of PMA-Zeolite.

Result

Blood aluminum levels remained unchanged after 3 months of daily intake. The stable SiO₄/AlO₄ lattice with high silicon content does not release aluminum.

Source: Clinical study — long-term safety data

Irritable bowel syndrome (IBS) — pilot study

Pilot study Peer-reviewed

Research question

Can PMA-Zeolite relieve IBS symptoms?

Method

Open-label pilot study with IBS patients. Recording of abdominal pain, bloating, stool consistency, and quality of life over 12 weeks.

Result

Significant improvement in abdominal pain, bloating, and stool consistency. Patients reported an improved quality of life.

Source: Peer-reviewed publication — pilot study on irritable bowel syndrome

Irritable bowel syndrome (IBS) — non-interventional study

NIS / real-world data

Research question

Are the pilot data confirmed under everyday conditions?

Method

Non-interventional study (NIS) with a larger patient group under everyday conditions. Documentation by treating physicians.

Result

Confirmation of the pilot results: IBS symptoms also improved under real-world everyday conditions in a broader patient group.

Source: Non-interventional study — medical documentation

Osteoporosis — randomized study

RCT Peer-reviewed

Research question

Does PMA-Zeolite have positive effects on bone health?

Method

Randomized controlled study. Measurement of bone density, bone formation and resorption markers, pain, and fracture rate.

Result

Bone density and bone formation markers increased. Bone resorption markers, pain, and fracture frequency decreased.

Source: Peer-reviewed publication — randomized controlled study

Osteoporosis — 5-year follow-up

Follow-up

Research question

Do the positive bone effects persist over the long term?

Method

5-year follow-up of the original osteoporosis study group. Long-term monitoring of bone density and fracture rate.

Result

The positive effects on bone health persisted even after 5 years. Long-term intake proved to be safe and well tolerated.

Source: Follow-up study — 5-year follow-up

Chemotherapy support — randomized study

RCT Peer-reviewed

Research question

Can PMA-Zeolite reduce the side effects of chemotherapy?

Method

Randomized controlled study with chemotherapy patients. Measurement of treatment adherence, nerve damage (CIPN), and side effects.

Result

More patients in the PMA-Zeolite group completed the planned chemotherapy cycles. In men, significantly fewer chemotherapy-induced nerve injuries (CIPN) occurred.

Source: Peer-reviewed publication — randomized controlled study

Chemotherapy — follow-up analysis

Follow-up

Research question

Are the chemotherapy results confirmed in follow-up?

Method

Follow-up and subgroup analysis of the original chemotherapy RCT. Differentiation by sex, tumor type, and treatment regimen.

Result

In certain subgroups, persistent benefits in chemotherapy tolerability were observed. The results support its use as a supportive measure.

Source: Follow-up analysis — subgroup evaluation

Blood parameters & oxidative stress

Safety Peer-reviewed

Research question

Does PMA-Zeolite affect blood parameters or oxidative stress?

Method

Controlled study. Comprehensive blood panel including liver/kidney values, electrolytes, antioxidants, and oxidation markers (MDA).

Result

All blood parameters remained within the normal range — liver and kidneys were not stressed. In addition: reduction of oxidative stress (MDA marker). PMA-Zeolite shows antioxidant properties.

Source: Peer-reviewed publication — controlled clinical study

Summary

What the research shows

The most important findings from over 50 publications at a glance.

Stronger intestinal barrier

Zonulin levels (leaky gut marker) decrease significantly. Intestinal wall integrity improves demonstrably.

Selective detoxification

Heavy metals are bound while nutrients remain unaffected. Ion exchange works selectively.

Long-term safety confirmed

No aluminum released. No burden on liver or kidneys. Safe even for long-term use.

Irritable bowel syndrome improved

Abdominal pain, bloating, and stool consistency improve in pilot and real-world studies.

Stronger bones

Bone density increases, resorption markers decrease. Effects persist even after 5 years.

Chemotherapy support

Better treatment adherence. Fewer nerve injuries in male patients.

FAQ

Questions about the study situation

Yes, PMA-Zeolite has been investigated in more than 50 publications, including randomized, double-blind, placebo-controlled studies (RCTs). The studies demonstrate effectiveness in strengthening the intestinal barrier, selective heavy metal binding, and safety during long-term use.

Yes, the most important PMA-Zeolite studies have been published in renowned scientific journals and have undergone the peer-review process. PANACEO works with internationally recognized research partners.

No. The studies relate exclusively to PMA-Zeolite with the patented PMA activation process. Results cannot be transferred to other zeolite products, as purity, activation, and particle size significantly influence effectiveness.

What is Zeolite

Effect, origin, and quality features →

Zeolite Application

Dosage, intake & course →

Why PMA-Zeolite?

The patented technology →

Product safety & toxicology

Strengthening the intestinal barrier (leaky gut)

Selective binding of harmful substances in the gut

No aluminum release

Irritable bowel syndrome (IBS) — pilot study

Irritable bowel syndrome (IBS) — non-interventional study

Osteoporosis — randomized study

Osteoporosis — 5-year follow-up

Chemotherapy support — randomized study

Chemotherapy — follow-up analysis

Blood parameters & oxidative stress

What the research shows

Stronger intestinal barrier

Selective detoxification

Long-term safety confirmed

Irritable bowel syndrome improved

Stronger bones

Chemotherapy support

Questions about the study situation

Learn more about zeolite

What is Zeolite

Zeolite Application

Why PMA-Zeolite?